Yahoo Web Search

  1. Ads
    related to ELI LILLY AND COMPANY
  1. Lilly Gets FDA Approval for New Oral Tablets for Migraine

    Zacks via Yahoo FinanceOct 14 14:14 PM

    Eli Lilly & Company LLY announced that the FDA has approved lasmiditan for the treatment of acute migraine headaches, with or without aura, in adults. Lasmiditan, an oral ...

  2. Novartis (NVS) Announces Data on Asthma Drugs & Kisqali

    Zacks via Yahoo FinanceOct 02 13:53 PM

    (PFE) : Free Stock Analysis Report Eli Lilly and Company (LLY) : Free Stock Analysis Report Roche Holding AG (RHHBY) : Free Stock Analysis Report Novartis AG (...

  3. This is Why Eli Lilly (LLY) is a Great Dividend Stock

    Zacks via Yahoo FinanceOct 15 13:15 PM

    Eli Lilly (LLY) is headquartered in Indianapolis, and is in the Medical sector. Eli Lilly has increased its dividend 5 times on a year-over-year basis over ...

  4. Pfenex Inc (NYSE: PFNX) has a key binary event coming up: mark your calendar for Oct. 7, when the FDA is scheduled to issue its verdict on the company's lead drug candidate. Through its ...

  5. The first half of the year was a mixed bag for big drug and biotech companies as far as earnings performance is concerned. While big names like Pfizer, Bristol-Myers and Lilly ...

  6. Today's Research Daily features new research reports on 16 major stocks, including Bank of America (BAC), The Home Depot (HD) and Philip Morris International (PM). These research reports ...

  7. The company has one of the broadest diabetes portfolios in the industry. A solid performance from Tresiba, Victoza, Ozempic, Xultophy and Saxenda drove sales in the first half ...

  8. Wall Street expects a year-over-year increase in earnings on lower revenues when Eli Lilly (LLY) reports results for the quarter ended September 2019. While this widely-known consensus ...

  9. BioNTech IPO: What You Need To Know

    Benzinga via Yahoo FinanceOct 08 11:55 AM

    The company expects to price the offering between $18 and $20 per ADS. At the midpoint of the estimated price range, the size of the offering is likely to be $250.8 million. The ...

  10. Importantly, patients who were treated with Tibsovo had a 6-month and 12-month PFS rate of 32% and 22%, respectively, while none of the patients in the placebo arm was free from ...

  1. Ads
    related to ELI LILLY AND COMPANY